Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

A View from Erika Jonietz

Stem Cell Sales Tactics

Commenting on California’s Prop 71 to fund stem cell research, my blogging colleague David Appell makes an excellent point about stem cells and Alzheimer’s, but he may be overstating the case a bit. An increasingly frequent–and legitimate–criticism of proponents of…

  • September 20, 2004

Commenting on California’s Prop 71 to fund stem cell research, my blogging colleague David Appell makes an excellent point about stem cells and Alzheimer’s, but he may be overstating the case a bit. An increasingly frequent–and legitimate–criticism of proponents of embryonic stem cell research is their tendency to link the cells with a treatment for Alzheimer’s (and tie such research to a legacy for President Reagan). However, as researchers point out, even if stem cells do not pan out as a therapy for Alzheimer’s, studies using the cells will still help patients by increasing our understanding of the disease. Such research could even lead to a new drug or other treatment that doesn’t use ES cells.

Singling out the tenuous Alzheimer’s link as a tactic being used to “sell” California voters on stem cells strikes me as a bit disingenuous. As David notes, there are at least 70 diseases, many of them common, such as diabetes and heart disease, that might be treated with stem cells. And there are countless others, such as Alzheimer’s and almost any form of cancer, that could be better understood through research using embryonic stem cells (as well as adult stem cells). It is indeed better to be up front with voters–about both the limits and the incredible potential of research on all types of stem cells.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.